Effect of Steroid Injection Which is Added to Percutaneous Trigger Finger Release: a Double-blinded Randomized Controlled Trial.

Sponsor
Samsung Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01781130
Collaborator
(none)
112
1
2
17
6.6

Study Details

Study Description

Brief Summary

Background

Present treatment strategies for trigger finger when conservative management including steroid injection was failed include percutaneous or open A1 pulley release, but some people showed prolonged swelling and delay of complete healing.

We aimed to test the hypothesis that an improved outcome can be achieved by employing steroid injection simultaneously with percutaneous release compared with conventional percutaneous release alone

Methods

We designed a double-blind, randomized controlled trial.

Inclusion criteria is the patient who has symptom of trigger finger warranted surgical release after sufficient time of conservative treatment.

Exclusion criteria are as follow: 1) multiple fingers at presentation; 2) Rheumatoid arthritis patients; 3) Pregnant or lactating patients; 4) Younger than 18 years old; 5) Previous surgery history of finger 6); the patients who got steroid injection more than 4 time previously; 7) coagulation abnormality including usage of anti-thrombotic agent.

After power analysis by a statistician, total 40 patients would be required for each group (percutaneous alone group versus percutaneous alone + steroid injection group).

The surgery will be performed by outpatients clinic basis with local injection. Additional steroid injection will be given to half of patients after allocation with randomized selection by permutaed block randomization.

Primary outcome measure is mean fall in pain visual analogue scale (pVAS) and secondary outcome will be proportion of patients with good response (defined as "Perfect" or "much better" as reported by patients).

Follow-up will be conducted 3 weeks and 3 month after index procedure

Condition or Disease Intervention/Treatment Phase
  • Procedure: Steroid injection
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
112 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Jun 1, 2014
Actual Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Percutaneous release alone

The patients who perform percutaneous release of trigger finger only

Experimental: Percutaneous release + Steroid injection

Steroid local injection after percutaneous release of trigger finger

Procedure: Steroid injection

Outcome Measures

Primary Outcome Measures

  1. pain VAS [3 month after procedure]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Trigger finger patients who require surgical intervention due to failuer of sufficient time of conservative treatment
Exclusion Criteria:
  • Age under 18 years old

  • Rheumatoid arthritis patients

  • Patients who got steroid injection more than 4 times previously

  • Multiple finger affected at presentation

  • Previous surgery history

  • Any recent trauma history of affected hand

Contacts and Locations

Locations

Site City State Country Postal Code
1 Samsung Medical Center Seoul Korea, Republic of 135-710

Sponsors and Collaborators

  • Samsung Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Min Jong Park, Professor, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01781130
Other Study ID Numbers:
  • 2012-11-112-002
First Posted:
Jan 31, 2013
Last Update Posted:
May 18, 2015
Last Verified:
May 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2015